| MicroRNA-25-dependent up-regulation of NADPH oxidase 4 (NOX4) mediates hypercholesterolemia-induced oxidative/nitrative stress and subsequent dysfunction in the heart ZV Varga, K Kupai, G Szűcs, R Gáspár, J Pálóczi, N Faragó, Á Zvara, ... Journal of molecular and cellular cardiology 62, 111-121, 2013 | 198 | 2013 |
| PARP inhibition protects against alcoholic and non-alcoholic steatohepatitis P Mukhopadhyay, B Horváth, M Rajesh, ZV Varga, K Gariani, D Ryu, ... Journal of hepatology 66 (3), 589-600, 2017 | 160 | 2017 |
| Alcohol misuse and kidney injury: epidemiological evidence and potential mechanisms ZV Varga, C Matyas, J Paloczi, P Pacher Alcohol research: current reviews 38 (2), 283, 2017 | 123 | 2017 |
| Neuroprotection in oxidative stress-related neurodegenerative diseases: role of endocannabinoid system modulation J Paloczi, ZV Varga, G Hasko, P Pacher Antioxidants & redox signaling 29 (1), 75-108, 2018 | 110 | 2018 |
| Macrophage P2X4 receptors augment bacterial killing and protect against sepsis B Csóka, ZH Németh, I Szabó, DL Davies, ZV Varga, J Pálóczi, S Falzoni, ... JCI insight 3 (11), 2018 | 106 | 2018 |
| β‐Caryophyllene protects against alcoholic steatohepatitis by attenuating inflammation and metabolic dysregulation in mice ZV Varga, C Matyas, K Erdelyi, R Cinar, D Nieri, A Chicca, BT Nemeth, ... British journal of pharmacology 175 (2), 320-334, 2018 | 93 | 2018 |
| Pepcan-12 (RVD-hemopressin) is a CB2 receptor positive allosteric modulator constitutively secreted by adrenals and in liver upon tissue damage V Petrucci, A Chicca, S Glasmacher, J Paloczi, Z Cao, P Pacher, J Gertsch Scientific reports 7 (1), 9560, 2017 | 79 | 2017 |
| Chronic plus binge ethanol feeding induces myocardial oxidative stress, mitochondrial and cardiovascular dysfunction, and steatosis C Matyas, ZV Varga, P Mukhopadhyay, J Paloczi, T Lajtos, K Erdelyi, ... American Journal of Physiology-Heart and Circulatory Physiology 310 (11 …, 2016 | 77 | 2016 |
| Discovery of a NAPE-PLD inhibitor that modulates emotional behavior in mice ED Mock, M Mustafa, O Gunduz-Cinar, R Cinar, GN Petrie, V Kantae, X Di, ... Nature chemical biology 16 (6), 667-675, 2020 | 72 | 2020 |
| PCSK9 inhibition as a novel therapeutic target for alcoholic liver disease JS Lee, P Mukhopadhyay, C Matyas, E Trojnar, J Paloczi, YR Yang, ... Scientific reports 9 (1), 17167, 2019 | 64 | 2019 |
| Bile acid–activated macrophages promote biliary epithelial cell proliferation through integrin αvβ6 upregulation following liver injury A Guillot, L Guerri, D Feng, SJ Kim, YA Ahmed, J Paloczi, Y He, ... The Journal of clinical investigation 131 (9), 2021 | 61 | 2021 |
| Interplay of liver–heart inflammatory axis and cannabinoid 2 receptor signaling in an experimental model of hepatic cardiomyopathy C Matyas, K Erdelyi, E Trojnar, S Zhao, ZV Varga, J Paloczi, ... Hepatology 71 (4), 1391-1407, 2020 | 59 | 2020 |
| Cannabinoid‐1 receptor deletion in podocytes mitigates both glomerular and tubular dysfunction in a mouse model of diabetic nephropathy T Jourdan, JK Park, ZV Varga, J Pálóczi, NJ Coffey, AZ Rosenberg, ... Diabetes, Obesity and Metabolism 20 (3), 698-708, 2018 | 58 | 2018 |
| Preconditioning protects the heart in a prolonged uremic condition GF Kocsis, M Sárközy, P Bencsik, M Pipicz, ZV Varga, J Pálóczi, ... American Journal of Physiology-Heart and Circulatory Physiology 303 (10 …, 2012 | 55 | 2012 |
| Disruption of renal arginine metabolism promotes kidney injury in hepatorenal syndrome in mice ZV Varga, K Erdelyi, J Paloczi, R Cinar, ZK Zsengeller, T Jourdan, ... Hepatology 68 (4), 1519-1533, 2018 | 53 | 2018 |
| Activation of PPARβ/δ protects cardiac myocytes from oxidative stress-induced apoptosis by suppressing generation of reactive oxygen/nitrogen species and expression of matrix … E Barlaka, A Görbe, R Gáspár, J Pálóczi, P Ferdinandy, A Lazou Pharmacological research 95, 102-110, 2015 | 50 | 2015 |
| Cholesterol-enriched diet inhibits cardioprotection by ATP-sensitive K+ channel activators cromakalim and diazoxide C Csonka, K Kupai, P Bencsik, A Görbe, J Pálóczi, Á Zvara, LG Puskás, ... American Journal of Physiology-Heart and Circulatory Physiology 306 (3 …, 2014 | 39 | 2014 |
| Moderate inhibition of myocardial matrix metalloproteinase-2 by ilomastat is cardioprotective P Bencsik, J Pálóczi, GF Kocsis, J Pipis, I Belecz, ZV Varga, C Csonka, ... Pharmacological Research 80, 36-42, 2014 | 38 | 2014 |
| Structural basis of selective cannabinoid CB2 receptor activation X Li, H Chang, J Bouma, LV de Paus, P Mukhopadhyay, J Paloczi, ... Nature Communications 14 (1), 1447, 2023 | 37 | 2023 |
| Cardioprotection by farnesol: role of the mevalonate pathway G Szűcs, Z Murlasits, S Török, GF Kocsis, J Pálóczi, A Görbe, T Csont, ... Cardiovascular drugs and therapy 27, 269-277, 2013 | 34 | 2013 |
Pal PacherNational Institutes of Health, BethesdaE-mail megerősítve itt: mail.nih.gov
